FI20155280A - Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita - Google Patents

Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita Download PDF

Info

Publication number
FI20155280A
FI20155280A FI20155280A FI20155280A FI20155280A FI 20155280 A FI20155280 A FI 20155280A FI 20155280 A FI20155280 A FI 20155280A FI 20155280 A FI20155280 A FI 20155280A FI 20155280 A FI20155280 A FI 20155280A
Authority
FI
Finland
Prior art keywords
glycan
prognostic
diagnostic
brain injury
based biomarkers
Prior art date
Application number
FI20155280A
Other languages
English (en)
Swedish (sv)
Inventor
Adrian Harel
Original Assignee
Medicortex Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicortex Finland Oy filed Critical Medicortex Finland Oy
Priority to FI20155280A priority Critical patent/FI20155280A/fi
Priority to DK16721191.1T priority patent/DK3283880T3/da
Priority to CA2982503A priority patent/CA2982503C/en
Priority to ES16721191T priority patent/ES2800039T3/es
Priority to US15/565,753 priority patent/US10739335B2/en
Priority to EP16721191.1A priority patent/EP3283880B1/en
Priority to PCT/FI2016/050246 priority patent/WO2016166419A1/en
Publication of FI20155280A publication Critical patent/FI20155280A/fi
Priority to IL254980A priority patent/IL254980B/en
Priority to US16/913,394 priority patent/US20200371093A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42Lectins, e.g. concanavalin, phytohaemagglutinin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants
    • G01N2333/42Lectins, e.g. concanavalin, phytohaemagglutinin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
FI20155280A 2015-04-15 2015-04-15 Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita FI20155280A (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20155280A FI20155280A (fi) 2015-04-15 2015-04-15 Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
DK16721191.1T DK3283880T3 (da) 2015-04-15 2016-04-14 Prognostiske og diagnostiske glycan-baserede biomarkører af hjerneskade
CA2982503A CA2982503C (en) 2015-04-15 2016-04-14 Prognostic and diagnostic glycan-based biomarkers of brain damage
ES16721191T ES2800039T3 (es) 2015-04-15 2016-04-14 Biomarcadores de prognóstico y de diagnóstico de lesiones cerebrales basados en glicanos
US15/565,753 US10739335B2 (en) 2015-04-15 2016-04-14 Prognostic and diagnostic glycan-based biomarkers of brain damage
EP16721191.1A EP3283880B1 (en) 2015-04-15 2016-04-14 Prognostic and diagnostic glycan-based biomarkers of brain damage
PCT/FI2016/050246 WO2016166419A1 (en) 2015-04-15 2016-04-14 Prognostic and diagnostic glycan-based biomarkers of brain damage
IL254980A IL254980B (en) 2015-04-15 2017-10-10 Prognostic and diagnostic glycan-based markers for brain damage
US16/913,394 US20200371093A1 (en) 2015-04-15 2020-06-26 Prognostic and Diagnostic Glycan-Based Biomarkers of Brain Damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155280A FI20155280A (fi) 2015-04-15 2015-04-15 Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Publications (1)

Publication Number Publication Date
FI20155280A true FI20155280A (fi) 2016-10-16

Family

ID=55948851

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20155280A FI20155280A (fi) 2015-04-15 2015-04-15 Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Country Status (8)

Country Link
US (2) US10739335B2 (fi)
EP (1) EP3283880B1 (fi)
CA (1) CA2982503C (fi)
DK (1) DK3283880T3 (fi)
ES (1) ES2800039T3 (fi)
FI (1) FI20155280A (fi)
IL (1) IL254980B (fi)
WO (1) WO2016166419A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018102138A6 (en) 2017-02-21 2019-09-19 Medicortex Finland Oy Non-invasive brain injury diagnostic device
US11016092B2 (en) 2017-03-23 2021-05-25 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1
WO2018191531A1 (en) 2017-04-15 2018-10-18 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
BR112019022476A2 (pt) 2017-04-28 2020-05-12 Abbott Laboratories Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano
CA3078725A1 (en) 2017-05-25 2018-11-29 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
BR112019025313A2 (pt) 2017-05-30 2020-06-23 Abbott Laboratories Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
EP3649474A1 (en) 2017-07-03 2020-05-13 Abbott Laboratories Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
EP3721228A4 (en) * 2017-12-06 2021-12-15 Flotbi Inc. ASSAY AND POINT OF CARE DEVICE USING SALIVA FOR DIAGNOSIS AND TREATMENT OF NEUROLOGICAL CONDITIONS AFFECTING BRAIN HEALTH
US11016105B2 (en) 2017-12-09 2021-05-25 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
EP3721233A2 (en) 2017-12-09 2020-10-14 Abbott Laboratories Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
EP3732489A1 (en) * 2017-12-29 2020-11-04 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
US20220214362A1 (en) * 2019-05-10 2022-07-07 Abbott Laboratories Evaluating biomarkers along with advanced magnetic resonance imaging procedures in a human subject that has sustained or may have sustained a head injury
FI20196004A1 (fi) * 2019-11-22 2021-05-23 Medicortex Finland Oy Laite ja menetelmä kohteen aivovamman detektoimiseksi
US20210311043A1 (en) 2020-04-06 2021-10-07 Medicortex Finland Oy Method for determining a lectin-binding glycan indicative to traumatic brain injury
WO2021236050A1 (en) 2020-05-18 2021-11-25 Baseline Global, Inc. Assay device, system, method, and kit
FI130428B (fi) * 2022-02-22 2023-08-24 Medicortex Finland Oy Menetelmä kudosvaurion havaitsemiseksi
DE202023100246U1 (de) 2022-04-05 2023-04-21 Medicortex Finland Oy Eine in der Hand haltbare Vorrichtung zum Sammeln und Testen von flüssigen Proben

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651581B1 (fr) 1989-09-06 1994-05-13 Centre Nal Recherc Scientifique Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US20060166290A1 (en) 2004-01-15 2006-07-27 Yale University Primary central nervous system tumor specific BEHAB isoforms
US7838634B2 (en) 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
JP4385149B2 (ja) 2005-05-11 2009-12-16 独立行政法人理化学研究所 血清糖蛋白質をバイオマーカーとするアルツハイマー病の診断薬
GB2428240A (en) * 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
JP5207469B2 (ja) 2006-09-06 2013-06-12 国立大学法人鳥取大学 アルツハイマーの診断キット、診断マーカー及び病態指標の検出方法
US20150369825A1 (en) * 2013-02-26 2015-12-24 Sophia SCHEDIN WEISS Diagnosis of Alzheimer Disease, Cognitive Decline and Dementia
US10534003B2 (en) * 2013-07-17 2020-01-14 The Johns Hopkins University Multi-protein biomarker assay for brain injury detection and outcome
WO2015130956A2 (en) 2014-02-28 2015-09-03 Exosome Sciences, Inc. Brain specific exosome based diagnostics and extracorporeal therapies

Also Published As

Publication number Publication date
IL254980B (en) 2021-07-29
IL254980A0 (en) 2017-12-31
US10739335B2 (en) 2020-08-11
CA2982503A1 (en) 2016-10-20
CA2982503C (en) 2021-07-13
US20180120305A1 (en) 2018-05-03
WO2016166419A1 (en) 2016-10-20
US20200371093A1 (en) 2020-11-26
EP3283880B1 (en) 2020-04-15
DK3283880T3 (da) 2020-06-29
ES2800039T3 (es) 2020-12-23
EP3283880A1 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
FI20155280A (fi) Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
CL2015003114S1 (es) Automovil
DK3140653T3 (da) Direkte immunhistokemianalyse
CL2015002393S1 (es) Automóvil
DK3129350T3 (da) Makrocyklusser
DK3172540T3 (da) Diagnostisk fremgangsmåde for vægt
DK3288467T3 (da) Biopsiindretning
DK3386954T3 (da) Dimere kontrastmidler
CL2015001956S1 (es) Automovil
ITUB20153347A1 (it) Apparato per la videocomunicazione
MA43957A (fr) Biomarqueurs de copanlisib
BR112017015217A2 (pt) chip diagnóstico
DK3098580T3 (da) Kombinationsvægtindretning
DK3198034T3 (da) Biomarkører for cervixcancer
CL2015002005S1 (es) Automovil
CL2015001801S1 (es) Automovil
CL2015002006S1 (es) Automovil
DK3190964T3 (da) Spirometer
BR112016018716A2 (pt) aparelho para medição.
DK2944469T3 (da) Blækhærdningsapparat
MA47259A (fr) Diagnostic
DE112014006578A5 (de) Führungseinrichtung
DE112016000139A5 (de) Sensorvorrichtung für Reifen
DK3211403T3 (da) Udvendigt inspektionsapparat
FR3033747B1 (fr) Dispositif de diagnostic

Legal Events

Date Code Title Description
FD Application lapsed